1 Min Read
FRANKFURT, Feb 19 (Reuters) - Bayer AG : * Says initiated phase III trial of VEGF Trap-Eye for the treatment of diabetic
macular edema in Asia and Russia
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.